Latest filing published 23 Jun 2021 for BioSig Technologies, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Samuel E. Navarro (board member) discloses dealings in 3 companies, chiefly STRATA Skin Sciences, Inc., Streamex Corp. and Derma Sciences, Inc. The record holds 20 filings, for trades running from 28 May 2015 to 21 June 2021.
No open-market sale appears; the market trades are 9 purchases worth €114k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 6 share grants and 3 option exercises.
Half of the purchases are above €7,298 and half below. Clusters matter here: 5 out of 6 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The record was last updated on 23 June 2021 with an option exercise in Streamex Corp. The most recent open-market purchase was published on 19 November 2019, 2,530 days ago. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations